Chugai Pharmaceutical Co., Ltd. (CHGCF)
OTC PINK OTC PINK Primary 
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript
Chugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q2 2025 Earnings Conference Call July 24, 2025 4:00 AM ET Company Participants a - Corporate Participant Iwaaki Taniguchi - Executive VP, Head of Finance Supervisory Division, CFO & Director Kae Miyata - Head of Corporate Communications Department Osamu Okuda - President, CEO & Chairman Tsukasa Kusano - Executive VP and Head of Project & Lifecycle Management Unit Conference Call Participants Akinori Ueda - Goldman Sachs Group, Inc., Research Division Fumiyoshi Sakai - UBS Investment Bank, Research Division Hidemaru Yamaguchi - Citigroup Inc., Research Division Kazuaki Hashiguchi - Daiwa Securities Co. Ltd.
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q4 2024 Earnings Call Transcript
Chugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q4 2024 Earnings Conference Call January 30, 2025 3:30 AM ET Company Participants Kae Miyata - Head of Corporate Communications Department Osamu Okuda - Representative Director, President, and Chief Executive Officer Michiaki Tanaka - Head, R&D Portfolio Management Department, Project and Lifecycle Management Unit Iwaaki Taniguchi - Director, Executive Vice President, and Chief Financial Officer Takao Suzuki - Associate Vice President, Head of the Digital Transformation Unit Conference Call Participants Kazuaki Hashiguchi - Daiwa Securities Fumiyoshi Sakai - UBS Securities Seiji Wakao - JPMorgan Securities Hidemaru Yamaguchi - Citigroup Global Markets Stephen Barker - Jefferies Tony Ren - Macquarie Capital Securities Shinichiro Muraoka - Morgan Stanley MUFG Securities Miki Sogi - AllianceBernstein Japan Kae Miyata Ladies and gentlemen, thank you for attending the conference on FY 2024 December financial results for Chugai Pharmaceutical.
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q3 2024 Earnings Call Transcript
Chugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q3 2024 Earnings Conference Call October 25, 2024 5:00 AM ET Company Participants Kae Miyata - Corporate Communications Department Osamu Okuda - President and CEO Tsukasa Kusano - Executive Vice President, Head, Project and Lifecycle Management Unit Iwaaki Taniguchi - Chief Financial Officer Junichi Takano - Head, Marketing and Sales Division Conference Call Participants Seiji Wakao - JPMorgan Hidemaru Yamaguchi - Citigroup Securities Shinichiro Muraoka - Morgan Stanley MUFG Securities Tony Ren - Macquarie Capital Hiroshi Wada - SMBC Nikko Securities Kazuaki Hashiguchi - Daiwa Securities Kasumi Haruta - UBS Securities Kae Miyata Thank you for joining Chugai Pharmaceutical's Earnings Call on the Financial Results for the Fiscal Year 2024 Third Quarter.
Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2024 Earnings Call Transcript
Chugai Pharmaceutical Co., Ltd. (OTCPK:CHGCF) Q2 2024 Earnings Conference Call July 24, 2024 4:00 AM ET Company Participants Kae Miyata - Head of Corporate Communications Osamu Okuda - President and Chief Executive Officer Tsukasa Kusano - Executive Vice President, Head of Project & Lifecycle Management Unit Iwaaki Taniguchi - Chief Financial Officer Conference Call Participants Shinichiro Muraoka - Morgan Stanley Matsubara - Nomura Securities Kasumi Haruta - UBS Securities Seiji Wakao - JPMorgan Securities Japan Co., Ltd.
